Zobrazeno 1 - 10
of 32
pro vyhledávání: '"V.M. Mishchenko"'
Autor:
I.M. Nikishkova, V.M. Mishchenko
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :42-47
To assess the efficacy of therapy in patients with asymptomatic brain lesions, such as «silent» brain infarcts (SBI), a number of electroencephalography (EEG) parameters can be used, as there is a correlation between EEG parameters and indices of n
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :25-31
В статье представлены данные исследования влияния препарата Глиатилин на выраженность неврологического дефицита, показатели повседне
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :13-19
The article deals with investigation of probability of cerebral atrophy (CA) formation according to magnetic resonance markers of cerebral small vessel disease (SVD). During the retrospective cohort study of the data from 308 patients aged 50 to 85 y
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :118-122
The article presents data from a study on the EEG-correlates of cerebral circulatory disorders and their relationship with risk of stroke in patients with multiple silent cerebral infarctions (mSCI). Analysis of bioelectrical activity of the brain wa
Autor:
T.S. Mishchenko, V.M. Mishchenko
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :95-100
Стаття присвячена лікуванню пацієнтів, які перенесли ішемічний інсульт. Зокрема, робиться акцент на терапії постінсультної спастичнос
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :63-69
An open-label clinical study on the efficacy and tolerability of the drug Muscomed, manufactured by World Medicine company, has been carried out in patients with muscular tonic syndromes. Muscomed contains thiocolchicoside as an active substance, a s
Autor:
V.M. Mishchenko
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :45-51
The article deals with the treatment of patients, who have suffered a stroke. The focus is on the correction of cognitive impairment. The data of the study on the influence of the generic drug Medotilin (choline alfoscerate) on the state of cognitive
Publikováno v:
INTERNATIONAL NEUROLOGICAL JOURNAL. :10-19
The article deals with the study of Sudorega effectiveness and safety in the treatment of patients with low back pain with neuropathic component. It was shown that the use of Sudorega at a dose of 75 mg twice daily for 30 days accelerated the relief
Autor:
V.M. Mishchenko, L.P. Zabrodina
Publikováno v:
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; Том 16, № 1 (2020); 42-49
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; Том 16, № 1 (2020); 42-49
INTERNATIONAL NEUROLOGICAL JOURNAL; Том 16, № 1 (2020); 42-49
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; Том 16, № 1 (2020); 42-49
INTERNATIONAL NEUROLOGICAL JOURNAL; Том 16, № 1 (2020); 42-49
In the article, prevalence, risk factors, pathogenetic mechanisms for the formation of cognitive impairment in post-stroke patients were described. The role of neurotrophic factors was demonstrated in the formation of a cognitive deficit in post-stro
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.